XML 21 R72.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Disclosures and Concentrations of Risk - Schedule of Reported Segment Revenues and Profit or Loss, and Reconciliation (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Revenue [1] $ 337,655 $ 214,094
Income (loss) before income taxes (213,252) 9,582
Acquisition and integration costs 2,791 17,052
Impairment loss 199,500  
Restructuring and related charges 742 1,591
Interest expense 21,664 7,666
Depreciation and amortization 14,763 3,582
Adjusted EBITDA 28,794 39,473
CEO    
Segment Reporting Information [Line Items]    
CEO transition costs 2,586  
Healthcare    
Segment Reporting Information [Line Items]    
Revenue 159,692 156,527
Adjusted EBITDA 30,242 26,129
Nutrition    
Segment Reporting Information [Line Items]    
Revenue 177,963 57,567
Adjusted EBITDA $ (1,448) $ 13,344
[1] The figure for total segments equals the consolidated figure for such item.